Abstract: A method of forming a semiconductor device includes patterning a dielectric layer to form a groove and depositing a plurality of conductive layers over the dielectric layer and in the groove. The first conductive layer is a liner layer, the second conductive layer is a metal film, and the third conductive layer is a capping layer. The first conductive layer is treated with a hydrogen plasma treatment to remove impurities. The first conductive layer is also treated with a hydrogen soak treatment to remove microvoids. The third conductive layer is treated with an ammonia plasma treatment to remove impurities. The third conductive layer is also treated with a hydrogen plasma treatment to remove additional impurities. The third conductive layer is also treated with a hydrogen soak treatment to remove microvoids.

Abstract: A method of forming a semiconductor device includes patterning a dielectric layer to form a groove and depositing a plurality of conductive layers over the dielectric layer and in the groove. The first conductive layer is a liner layer, the second conductive layer is a metal film, and the third conductive layer is a capping layer. The first conductive layer is treated with a hydrogen plasma treatment to remove impurities. The first conductive layer is also treated with a hydrogen soak treatment to remove microvoids. The third conductive layer is treated with an ammonia plasma treatment to remove impurities. The third conductive layer is also treated with a hydrogen plasma treatment to remove additional impurities. The third conductive layer is also treated with a hydrogen soak treatment to remove microvoids.

Abstract: A method for determining a disease state transition path includes receiving a patient data having functional data and/or structural data related to a patient. Based on the patient data, a first disease state of a plurality of non-overlapping disease states each associated with a predetermined range of functional and/or structural degeneration values may be identified. A second, non-adjacent disease state of the plurality of disease states may be identified based on the patient data. A most probable path between the first disease state and the second disease state may be determined using a two dimensional continuous-time hidden Markov model.

Abstract: A method for determining a disease state transition path includes receiving a patient data having functional data and/or structural data related to a patient. Based on the patient data, a first disease state of a plurality of non-overlapping disease states each associated with a predetermined range of functional and/or structural degeneration values may be identified. A second, non-adjacent disease state of the plurality of disease states may be identified based on the patient data. A most probable path between the first disease state and the second disease state may be determined using a two dimensional continuous-time hidden Markov model.

Abstract: Systems and methods of analyzing an optical coherence tomography image of a retina are discussed. A 2-dimensional slice of the image can be aligned to produce an approximately horizontal image of the retina and an edge map based at least in part on the aligned slice. Also, at least one global representation can be determined based on a (multi-scale) spatial division, such as multi-scale spatial pyramid, on the slice and/or edge map. Creating the local features is based on the specified cell structure of the global representation. The local features can be constructed based on local binary pattern (LBP)-based features. Additionally, a slice can be categorized into one or more categories via one or more classifiers (e.g., support vector machines). Each category can be associated with at least one ocular pathology, and classifying can be based on the constructed global descriptors, which can include the LBP-based local descriptors.

Abstract: The present invention provides a pharmaceutically acceptable compound, a pharmaceutical composition comprising the above-mentioned pharmaceutically acceptable compound. The pharmaceutically acceptable compound provided by the present invention is a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid and has the ability to be used to manufacture medicaments for treating and/or preventing cough, ameliorating pains, treating respiratory system diseases, treating cardiovascular diseases and treating liver diseases.

Abstract: The present invention provides a pharmaceutically acceptable compound, a pharmaceutical composition comprising the above-mentioned pharmaceutically acceptable compound. The pharmaceutically acceptable compound provided by the present invention is a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid and has the ability to be used to manufacture medicaments for treating and/or preventing cough, ameliorating pains, treating respiratory system diseases, treating cardiovascular diseases and treating liver diseases.

Abstract: Systems and methods of analyzing an optical coherence tomography image of a retina are discussed. A 2-dimensional slice of the image can be aligned to produce an approximately horizontal image of the retina and an edge map based at least in part on the aligned slice. Also, at least one global representation can be determined based on a (multi-scale) spatial division, such as multi-scale spatial pyramid, on the slice and/or edge map. Creating the local features is based on the specified cell structure of the global representation. The local features can be constructed based on local binary pattern (LBP)-based features. Additionally, a slice can be categorized into one or more categories via one or more classifiers (e.g., support vector machines). Each category can be associated with at least one ocular pathology, and classifying can be based on the constructed global descriptors, which can include the LBP-based local descriptors.

Abstract: Disclosed is a digital television system, which comprises: a receiving module, for receiving a television signal; a parser, coupled to the receiving module, for extracting EPG (ELECTRONIC PROGRAM GUIDE) data of the television signal; a storing device, coupled to the parser, for storing the EPG data; a control signal receiving interface, for receiving a control signal from a remote control device; a processor, coupled to the storing device and the control signal receiving interface, for accessing at least a part of the EPG data according to the control signal; a display; a blender, coupled to the processor and the display, for displaying the EPG data outputted from the processor on the display; wherein the control signal comprises a channel number information.

Abstract: A method is disclosed for displaying an electronic program guide. The electronic program guide includes a plurality of time attributes associated with a plurality of program attributes, respectively. The method disclosed for displaying an electronic program guide includes providing a plurality of time indicators; displaying at least a specific time attribute and its associated program attribute; and when the specific time attribute and its associated program attribute are selected, playing a specific time indicator associated with the selected specific time attribute.

Abstract: A method and device for displaying content of a region of interest within a video image is disclosed. The method includes: receiving a video signal from a video source; decoding the video signal to generate a video data corresponding to the video image; receiving at least a user command to modify the region of interest; and displaying the content of the modified region of interest on a screen according to part of the video data corresponding to the modified region of interest.

Abstract: The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes.

Abstract: The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes.

Abstract: The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes.